SINTOMAS NEUROLÓGICOS APRESENTADOS POR PESSOAS COM COVID-19 LONGA: REVISÃO DE ESCOPO

Bianca Cristina Galatti; Gustavo Diego Magno; Silvia Carla da Silva André Uehara

doi:10.31011/reaid-2026-v.100-n.3-art.2701

Autores

Bianca Cristina Galatti Universidade Federal de São Carlos (UFSCar) https://orcid.org/0009-0008-4030-243X
Gustavo Diego Magno Universidade Federal de São Carlos https://orcid.org/0000-0003-3656-9170
Silvia Carla da Silva André Uehara niversidade Federal de São Carlos (UFSCar) https://orcid.org/0000-0002-0236-5025

DOI:

https://doi.org/10.31011/reaid-2026-v.100-n.3-art.2701

Palavras-chave:

Síndrome de Pós-COVID-19 Aguda, Manifestações Neurológicas, COVID-19, Sinais e Sintomas

Resumo

Objetivo: analisar os sintomas neurológicos desenvolvidos por pessoas com COVID-19 longa. Métodos: trata-se de uma revisão de escopo realizada nas bases de dados Web of Science, MEDLINE, LILACS, SCOPUS, SCIELO, Google Scholar e LitCovid. Para a inclusão, considerou-se artigos que abordaram: influência da idade, sexo, presença de comorbidades e situação vacinal. Resultados: foram selecionados nove estudos, que mostram os sintomas neurológicos mais comuns na COVID-19 longa como cefaleia, distúrbios do sono, fadiga e déficit cognitivo. Esses sintomas foram descritos em diferentes faixas etárias, sendo mais prevalentes em pessoas idosas e com comorbidades. Alguns estudos apontando maior prevalência em mulheres, enquanto outros não identificaram diferenças significativas. Já a situação vacinal foi pouco explorada, sem associações consistentes com desfechos neurológicos. Conclusão: a COVID-19 longa com manifestações neurológicos permanece um desafio em saúde pública, com impacto relevante na qualidade de vida. Persistem lacunas sobre o papel do sexo e da vacinação, evidenciando a necessidade de pesquisas mais robustas que orientem estratégias de prevenção e cuidado.

Downloads

Não há dados estatísticos.

Referências

1. Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601-15. doi: https://doi.org/10.1038/s41591-021-01283-z

2. The Lancet. Facing up to long COVID. Lancet. 2020;396(10266):1861. doi: https://doi.org/10.1016/S0140-6736(20)32662-3

3. World Health Organization. A clinical case definition of post COVID-19 condition by a Delphi consensus. Geneve: WHO; 6 Oct 2021 [Internet]. 2021 [cited Sep 25, 2025]. Available from: https://iris.who.int/server/api/core/bitstreams/53c01712-a322-446e-ad9f-4e078b757267/content

4. Ministério da Saúde (BR). Nota Técnica nº 57/2023 – DGIP/SE/MS. Atualizações acerca das "condições pós-covid" no âmbito do Ministério da Saúde [Internet]. Brasília-DF: Ministério da Saúde; 2023 [cited 2025 Aug 14]. Available from: https://bvsms.saude.gov.br/bvs/publicacoes/nota_tecnica_n57_atualizacoes_condicoes_poscovid.pdf

5. Prediger KM, Ribeiro AC, Uehara SCDSA. Prevalent symptoms and characteristics of the Long COVID-19 population: a scoping review. Rev Latino-Am Enfermagem. 2025;33:e4479. doi: https://doi.org/10.1590/1518-8345.7353.4479

6. Marchi M, Grenzi P, Serafini V, Capoccia F, Rossi F, Marrino P, et al. Psychiatric symptoms in Long-COVID patients: a systematic review. Front Psychiatry. 2023;14:1138389. doi: https://doi.org/10.3389/fpsyt.2023.1138389

7. Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond). 2021;53(10):737-54. doi: https://doi.org/10.1080/23744235.2021.1924397

8. Zawilska JB, Kuczyńska K. Psychiatric and neurological complications of long COVID. J Psychiatr Res. 2022;156:349-60. doi: https://doi.org/10.1016/j.jpsychires.2022.10.045

9. Aromataris E, Lockwood C, Porritt K, Pilla B, Jordan Z. JBI manual for evidence synthesis [Internet]. 2024 [cited Aug 13, 2025]. Available from: https://jbi-global-wiki.refined.site/download/attachments/355599504/JBI%20Manual%20for%20Evidence%20Synthesis%202024.pdf

10. Laboratório de Pesquisa em Engenharia de Software (LaPES). StArt – State of the Art through Systematic Review [Internet]. 2020 [cited Sep 24, 2025]. Available from: https://www.lapes.ufscar.br/resources/tools-1/start-1

11. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi: https://doi.org/10.1136/bmj.n71

12. Alghamdi HY, Alrashed AM, Jawhari AM, Abdel-Moneim AS. Neuropsychiatric symptoms in post-COVID-19 long haulers. Acta Neuropsychiatr. 2022;34(6):318-29. doi: https://doi.org/10.1017/neu.2022.13

13. Frontera JA, Yang D, Lewis A, Patel P, Medicherla C, Arena V, et al. A prospective study of long-term outcomes among hospitalized COVID-19 patients with and without neurological complications. J Neurol Sci. 2021;426:117486. doi: https://doi.org/10.1016/j.jns.2021.117486

14. Sun B, Tang N, Peluso MJ, Iyer NS, Torres L, Donatelli JL, et al. Characterization and Biomarker Analyses of Post-COVID-19 Complications and Neurological Manifestations. Cells. 2021;10(2):386. doi: https://doi.org/10.3390/cells10020386

15. Pilotto A, Benussi A, Libri I, Masciocchi S, Poli L, Premi E, et al. COVID-19 severity impacts on long-term neurological manifestation after hospitalisation. medRxiv [preprint]. 2024;2020.12.27.20248903. doi: https://doi.org/10.1007/s10072-021-05586-4

16. Graham EL, Clark JR, Orban ZS, Lim PH, Szymanski AL, Taylor C, et al. Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 "long haulers". Ann Clin Transl Neurol. 2021;8(5):1073-85. doi: https://doi.org/10.1002/acn3.51350

17. Magdy R, Elsayad GF, Selim S, El-Ebiary A, Abd ElMonem A, El‐Tantawy O, et al. Post-COVID-19 neuropsychiatric manifestations among COVID-19 survivors suffering from migraine: a case-control study. J Headache Pain. 2022;23(1):101. doi: https://doi.org/10.1186/s10194-022-01468-y

18. Hosp JA, Reisert M, Dressing A, Götz V, Kellner E, Mast H, et al. Cerebral microstructural alterations in Post-COVID-condition are related to cognitive impairment, olfactory dysfunction and fatigue. Nat Commun. 2024;15(1):4256. doi: https://doi.org/10.1038/s41467-024-48651-0

19. Cristillo V, Pilotto A, Cotti Piccinelli S, Zoppi N, Bonzi G, Gipponi S, et al. Age and subtle cognitive impairment are associated with long-term olfactory dysfunction after COVID-19 infection. J Am Geriatr Soc. 2021;69(10):2778‑80. doi: https://doi.org/10.1111/jgs.17296

20. Sedat Y, Erman A, Yasemin FE. Post-acute sequelae of COVID-19 in young adults: Mental fatigue and decreased cognitive flexibility. Ideggyogy Sz. 2023;76(7-8):261-9. doi: https://doi.org/10.18071/isz.76.0261

21. Kubota T, Kuroda N, Sone D. Neuropsychiatric aspects of long COVID: A comprehensive review. Psychiatry Clin Neurosci. 2023;77(2):84-93. doi: https://doi.org/10.1111/pcn.13508

22. Popa E, Popa AE, Poroch M, Poroch V, Ungureanu MI, Slanina AM, et al. The molecular mechanisms of cognitive dysfunction in long COVID: a narrative review. Int J Mol Sci. 2025;26(11):5102. doi: https://doi.org/10.3390/ijms26115102

23. Kadl A, Davis EM, Oliver SF, Lazoff SA, Popovich J, Atya AAE, et al. Prevalence and associations of insomnia after COVID-19 infection. J Clin Sleep Med. 2025;21(2):383-91. doi: https://doi.org/10.5664/jcsm.11420

24. Deng J, Zhou F, Hou W, Silver Z, Wong CY, Chang O, et al. The prevalence of depression, anxiety, and sleep disturbances in COVID-19 patients: a meta-analysis. Ann N Y Acad Sci. 2021;1486(1):90-111. doi: https://doi.org/10.1111/nyas.14506

25. Miskowiak KW, Fugledalen L, Jespersen AE, Sattler SM, Podlekareva D, Rungby J, et al. Trajectory of cognitive impairments over 1 year after COVID-19 hospitalisation: Pattern, severity, and functional implications. Eur Neuropsychopharmacol. 2022;59:82-92. doi: https://10.1016/j.euroneuro.2022.04.004

26. Schilling C, Nieters A, Schredl M, Peter RS, Rothenbacher D, Brockmann SO, et al. Pre-existing sleep problems as a predictor of post-acute sequelae of COVID-19. J Sleep Res. 2023;33(2):e13949. doi: https://doi.org/10.1111/jsr.13949

27. Chang L, Ryan MC, Liang H, Zhang X, Cunningham E, Wang J, et al. Changes in brain activation patterns during working memory tasks in people with post-COVID condition and persistent neuropsychiatric symptoms. Neurology. 2023;100(23):e2409-23. doi: https://doi.org/10.1212/wnl.0000000000207309

28. Buonsenso D, Pujol FE, Munblit D, Pata D, McFarland S, Simpson FK. Clinical characteristics, activity levels and mental health problems in children with long coronavirus disease: a survey of 510 children. Future Microbiol. 2022;17(8):577-88. doi: https://doi.org/10.2217/fmb-2021-0285

29. Choudhury NA, Mukherjee S, Singer T, Venkatesh A, Perez Giraldo GS, Jimenez M et al. Neurologic Manifestations of Long COVID Disproportionately Affect Young and Middle-Age Adults. Ann Neurol. 2025;97(2):369-83. doi: https://doi.org/10.1002/ana.27128

30. Cintra FCMDC, Cintra MT, Almeida DCB, Martins DM, Simão GRDB, Filipin CS, et al. Prospective cohort of elderly patients after hospitalization due to COVID‐19: preliminary results. Alzheimers Dement. 2022;18(Suppl 8):e065552. doi: https://doi.org/10.1002/alz.065552

31. Li Z, Zhang Z, Zhang Z, Wang Z, Li H. Cognitive impairment after long COVID-19: current evidence and perspectives. Front Neurol. 2023;14:1239182. doi: https://doi.org/10.3389/fneur.2023.1239182

32. Calcaterra V, Zanelli S, Foppiani A, Verduci E, Benatti B, Bollina R, et al. Long COVID in children, adults, and vulnerable populations: a comprehensive overview for an integrated approach. Diseases. 2024;12(5):95. doi: https://doi.org/10.3390/diseases12050095

33. Fernández-de-Las-Peñas C, Martín-Guerrero JD, Pellicer-Valero ÓJ, Navarro-Pardo E, Gómez-Mayordomo V, Cuadrado ML, et al. Female sex is a risk factor associated with long-term post-COVID related-symptoms but not with COVID-19 symptoms: The LONG-COVID-EXP-CM Multicenter Study. J Clin Med. 2022;11(2):413. doi: https://doi.org/10.3390/jcm11020413

34. Gorenshtein A, Liba T, Leibovitch L, Stern S, Stern Y. Intervention modalities for brain fog caused by long-COVID: systematic review of the literature. Neurol Sci. 2024;45(7):2951-68. doi: https://doi.org/10.1007/s10072-024-07566-w

35. Ciarambino T, Para O, Giordano M. Immune system and COVID-19 by sex differences and age. Womens Health (Lond). 2021;17:17455065211022262. doi: https://doi.org/10.1177/17455065211022262

36. Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220-32. doi: https://doi.org/10.1016/s0140-6736(20)32656-8

37. Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626 31. doi: https://doi.org/10.1038/s41591-021-01292-y

38. Greene C, Connolly R, Brennan D, Laffan A, O’Keeffe E, Zaporojan L, et al. Blood–brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment. Nat Neurosci. 2024;27:421-32. doi: https://doi.org/10.1038/s41593-024-01576-9

39. Notarte KI, Catahay JA, Velasco JV, Pastrana A, Ver AT, Pangilinan FC, et al. Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: a systematic review. EClinicalMedicine. 2022;53:101624. doi: https://doi.org/10.1016/j.eclinm.2022.101624

40. Ayoubkhani D, Bermingham C, Pouwels KB, Glickman M, Nafilyan V, Zaccardi F, et al. Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study. BMJ. 2022;377:e069676. doi: https://doi.org/10.1136/bmj-2021-069676